Skip to content
value.today

Five Prime Therapeutics Inc.

Total raised
$39 M
3 rounds on record
Latest round
$21 M
Mar 2014
First round on record
Aug 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Five Prime Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2014$21 MNo. 3$10 to $50 million

Five Prime Therapeutics Inc.: Raise no. 3, Mar 2014

Investors in this round

1 investor had bought by the notice of Mar 26, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $21 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aron M. Knickerbocker · Executive Officer, Director
  • Francis W. Sarena · Executive Officer
  • Julie L. Hambleton, M.D. · Executive Officer
  • Lewis T. Williams · Executive Officer, Director
  • Marc L. Belsky · Executive Officer
  • W. Michael Kavanaugh, M.D. · Executive Officer
  • Brian G Atwood · Director
  • Franklin M. Berger, CFA · Director
  • Fred E. Cohen, M.D., D.Phil. · Director
  • Mark D. McDade · Director
  • Peder K. Jensen, M.D. · Director
  • R. Lee Douglas · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Francis W. Sarena, Senior Vice President, General Counsel and Secretary. Source: SEC Form D, newest notice filed Mar 26, 2014. Read the notice at the SEC.

equitySEC
Apr 2012$10 MNo. 2$10 to $50 million

Five Prime Therapeutics Inc.: Raise no. 2, Apr 2012

Investors in this round

1 investor had bought by the notice of Apr 20, 2012: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aron Michael Knickerbocker · Executive Officer
  • Francis K Sarena · Executive Officer
  • Lauretta Michael Cesario · Executive Officer
  • Lewis T Williams · Executive Officer, Director
  • Marc Michael Belsky · Executive Officer
  • W. Michael Kavanaugh · Executive Officer
  • Brian K Atwood · Director
  • Brook K Byers · Director
  • Franklin T Berger · Director
  • Fred K Cohen · Director
  • Mark T McDade · Director
  • Peder K Jensen · Director
  • Robert Lee Douglas · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Francis Sarena, Vice President, General Counsel and Secretary. Source: SEC Form D, newest notice filed Apr 20, 2012. Read the notice at the SEC.

equitySEC
Aug 2010$8 MNo. 1$2 to $10 million

Five Prime Therapeutics Inc.: Raise no. 1, Aug 2010

Investors in this round

1 investor had bought by the notice of Sep 16, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julia P. Gregory · Executive Officer, Director
  • Lewis T. Williams · Executive Officer, Director
  • Brian Lee Atwood · Director
  • Brook Lee Byers · Director
  • Franklin P. Berger · Director
  • Fred Lee Cohen · Director
  • James Lee Blair · Director
  • Mark P. McDade · Director
  • Robert Lee Douglas · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Laura A. Berezin, Secretary. Source: SEC Form D, newest notice filed Sep 16, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Five Prime Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2014).

    SEC Form D · Mar 2014

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2014

That is all the official record says: Five Prime Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Five Prime Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 1 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Five Prime Therapeutics Inc.
NameRoleNamed in
Aron M. KnickerbockerExecutive officerMar 2014
Francis W. SarenaExecutive officerMar 2014
Julie L. Hambleton, M.D.Executive officerMar 2014
Lewis T. WilliamsExecutive officerMar 2014
Marc L. BelskyExecutive officerMar 2014
W. Michael Kavanaugh, M.D.Executive officerMar 2014
Aron Michael KnickerbockerExecutive officerApr 2012
Francis K SarenaExecutive officerApr 2012
Lauretta Michael CesarioExecutive officerApr 2012
Lewis T WilliamsExecutive officerApr 2012
Marc Michael BelskyExecutive officerApr 2012
W. Michael KavanaughExecutive officerApr 2012
Julia P. GregoryExecutive officerSep 2010
Aron M. KnickerbockerDirectorMar 2014
Brian G AtwoodDirectorMar 2014
Franklin M. Berger, CFADirectorMar 2014
Fred E. Cohen, M.D., D.Phil.DirectorMar 2014
Lewis T. WilliamsDirectorMar 2014
Mark D. McDadeDirectorMar 2014
Peder K. Jensen, M.D.DirectorMar 2014
R. Lee DouglasDirectorMar 2014
Brian K AtwoodDirectorApr 2012
Brook K ByersDirectorApr 2012
Franklin T BergerDirectorApr 2012
Fred K CohenDirectorApr 2012
Lewis T WilliamsDirectorApr 2012
Mark T McDadeDirectorApr 2012
Peder K JensenDirectorApr 2012
Robert Lee DouglasDirectorApr 2012
Brian Lee AtwoodDirectorSep 2010
Brook Lee ByersDirectorSep 2010
Franklin P. BergerDirectorSep 2010
Fred Lee CohenDirectorSep 2010
James Lee BlairDirectorSep 2010
Julia P. GregoryDirectorSep 2010
Mark P. McDadeDirectorSep 2010